Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regulatory News In Brief

This article was originally published in The Gray Sheet

Executive Summary

IOM to release 510(k) report this week

You may also be interested in...



Massachusetts Device Makers Urge FDA To Abandon Controversial 510(k) Reform Proposals

Massachusetts device makers are pressing FDA to abandon the controversial 510(k) reform recommendations currently awaiting input from the Institute of Medicine.

FDA Says Some Notice-To-Industry Letters Will Be Level 1 Guidance

FDA says some of its new "notice-to-industry" letters will have the same force as agency guidance documents that take effect immediately.

FDA: Draft Guidance For Laboratory-Developed Test Regs Taking Extra Time

The head of FDA’s diagnostics office is hopeful that draft guidance governing laboratory-developed tests will be issued by year-end, but cautioned that the process is taking more time than expected.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT030377

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel